Multiple Sclerosis Trial, Recruiting (NCT06330350)

Multiple Sclerosis Trial, Recruiting NCT06330350 Sponsor: Maastricht University Medical Center Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06330350 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult who has been diagnosed with a genetic skin condition (such as a disorder affecting skin texture, skin fragility, sweat glands/hair/nails, skin cancer syndromes, or other inherited skin diseases) and you would like to have children — your partner may also be included if they share this wish
Your genetic skin condition has been confirmed both by a doctor's examination and by genetic testing
Healthcare professionals who work with patients who have genetic skin conditions (such as geneticists or dermatologists) may also be able to take part

Who may not be able to join:

You are not able to have a conversation in Dutch or English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antoni Gostynski, MD, PhD, Maastricht University Medical Center

Phone: +31433877293

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06330350

Sponsor: Maastricht University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +31433877293

More information: https://clinicaltrials.gov/study/NCT06330350

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult who has been diagnosed with a genetic skin condition (such as a disorder affecting skin texture, skin fragility, sweat glands/hair/nails, skin cancer syndromes, or other inherited skin diseases) and you would like to have children — your partner may also be included if they share this wish
Your genetic skin condition has been confirmed both by a doctor's examination and by genetic testing
Healthcare professionals who work with patients who have genetic skin conditions (such as geneticists or dermatologists) may also be able to take part

Who may not be able to join:

You are not able to have a conversation in Dutch or English

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Maastricht University Medical Center

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

31 August 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Assessment of perspectives of affected patients + partners and of healthcare professionals concerning reproductive decision-making

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov